文献速递临床试验与 GCP流行病学与生物统计

多阶段随机对照试验的早期次要结局分析:HeLTI的务实方法

Early secondary outcome analysis in multi-phase randomised-controlled trials, a pragmatic approach: the Healthy Life Trajectories Initiative (HeLTI).
PubMed 文献 · Trials · 2026-04-30

针对HeLTI等多阶段随机对照试验因主要结局未达成而延迟所有分析的问题,该文描述了HeLTI领导层通过专家小组反馈制定分析策略的过程。多数评审者认为等到主要结局后再分析不切实际,最终领导层同意采用预先约定的分阶段方法,允许在主要结局前发表次要结局的组间比较及关联机制研究。

要点

  • 多阶段试验可预先约定分阶段分析策略,避免所有分析延迟至主要结局达成。
  • 在主要结局前发表次要结局组间比较需基于事先约定并谨慎评估。
  • 该策略有助于机制研究和年轻研究者参与,但需平衡统计严谨性。

核心结论

  • HeLTI领导层同意采用预先约定的分阶段方法,允许在主要结局达成前发表次要结局的组间比较及关联机制研究。

研究设计与样本

  • 该研究为方法学论述,描述了HeLTI领导层制定分析策略的过程,涉及召集具有相关学科广泛知识的专家小组。

主要发现

  • 部分评审者强调仅在主要结局达成后进行分析的重要性,但多数评审者指出在HeLTI联盟背景下等待不切实际,会错过有价值的 interim 分析。

临床怎么用

  • 对于周期长的多阶段随机对照试验,可考虑预先约定分阶段分析计划,以平衡主要结局严谨性与早期次要结局及机制研究的及时发布。

局限性

  • 原文未报告该分阶段分析方法的实际应用效果、具体统计考量或潜在偏倚风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The extended time frame of some trials can cause significant challenges in delaying all analyses until the primary outcome is attained. This may particularly affect any mechanistic studies linked to secondary outcomes, as well as impact the involvement of trainees and junior investigators in the project. This manuscript describes the strategy and process by which the leadership of the Healthy Life Trajectories Initiative (HeLTI) developed an analysis approach. METHODS: The study involved the engagement of an expert panel with broad knowledge in disciplines relevant to the study. RESULTS: Several reviewers emphasised the importance of undertaking analysis only after the primary outcome has been achieved. However, the majority of reviewers highlighted that this was not practical in the context of the HeLTI consortium because valuable interim analysis would be missed. CONCLUSION: After careful consideration of the issue and feedback received, the HeLTI leadership agreed to an approach that allowed publishing between-group comparisons of secondary outcomes and linked mechanistic studies before the primary outcome, using an a priori agreed phased approach.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Kumaran K, Baillargeon JP, Birken CS, et al. Early secondary outcome analysis in multi-phase randomised-controlled trials, a pragmatic approach: the Healthy Life Trajectories Initiative (HeLTI). Trials. 2026. PMID: 42057197. doi:10.1186/s13063-026-09737-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。